Solesence, Inc.

SLSN Consumer Defensive Household & Personal Products

Solesence, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.1 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 24.7%, EPS fell 105.5%, free cash flow grew 86.5% and total debt rose 36.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.02 0.00 0.00%
Market cap
$70.7M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
2/9
Altman Z
1.02
Beneish M
−1.13
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 34.55 79.71 0.00 0.00 37.48 82.90
Piotroski F-Score
3 2 1 2 4 6 1 1 7 2
P/S ratio
2.06 1.31 1.74 0.82 1.89 6.72 1.49 0.80 2.91 1.81
Altman Z-Score
(19.03) (16.07) (16.63) (13.84) (6.71) 2.39 (1.99) (3.08) 1.26 1.02
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 443.16 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
(61.33) (46.76) (49.25) (36.45) (22.02) (9.22) (9.42) (10.89) (4.94) (3.70)
Beneish M-Score
(3.76) (1.23) (3.35) 37.53 (0.36) (0.88) (2.49) (3.16) (2.07) (1.13)
P/Operating CF
196.96 (173.35) (58.73) (16.66) (98.59) 96.54 74.30 (11.22) 69.50 61.87
P/B ratio
7.97 5.04 17.87 6.78 11.87 26.54 9.83 15.63 10.18 7.99
Price to Tangible BV
7.97 5.04 17.87 6.78 11.87 26.54 9.83 15.63 10.18 7.99
EV/Sales
1.93 1.20 1.73 0.85 1.99 6.77 1.65 1.04 3.09 2.04
EV/EBITDA
0.00 0.00 0.00 0.00 16.18 50.93 0.00 0.00 26.72 51.25
EV/Operating CF
(86.26) (15.58) (18.32) (3.84) (16.56) 85.93 (37.33) (19.35) 82.15 (14.77)
EV/FCF
(51.20) (14.49) (16.37) (3.03) (11.62) 446.18 (13.77) (12.70) (62.59) (11.81)
Quick Ratio
1.71 1.52 0.60 0.49 0.57 0.63 0.50 0.33 0.24 0.58
Current Ratio
2.64 2.28 1.29 1.13 1.30 1.58 1.20 1.05 1.14 2.07
Net Debt/EBITDA
2.54 3.60 0.20 (0.17) 0.81 0.09 (3.60) (3.24) 0.59 5.66
Debt/Assets
2.27% 6.64% 15.31% 17.26% 19.64% 3.54% 24.68% 32.88% 10.00% 30.50%
Debt/Equity
0.04 0.13 0.73 1.07 0.97 0.13 1.47 5.68 0.33 0.87
Asset Turnover
2.29 2.25 2.21 1.57 1.49 1.41 1.20 1.12 1.26 1.24
Operating CF/Net income
0.19 1.22 0.64 0.92 (2.08) 1.00 0.63 0.46 0.47 (4.79)
Capex/Depreciation
(0.27) (0.21) (0.50) (2.14) (1.40) (1.38) (4.98) (1.42) (4.91) (2.39)
Interest Coverage
(84.53) (22.71) (34.88) (13.31) 2.99 2.22 (5.91) (4.23) 7.66 1.69
ROE
(45.40%) (26.20%) (90.16%) (207.67%) 46.62% 45.50% (40.00%) (116.28%) 50.27% 10.99%
ROA
(27.25%) (14.21%) (32.43%) (37.71%) 8.63% 11.07% (8.47%) (13.22%) 10.22% 3.58%
ROIC
(70.63%) (28.50%) (120.99%) (90.31%) 20.93% 20.47% (12.02%) (20.17%) 17.30% 3.11%
Return on Tangible Assets
(36.40%) (18.68%) (71.34%) (106.18%) 20.11% 25.86% (24.42%) (46.80%) 25.97% 6.14%
Average Days of Receivables
14.69 32.63 21.32 28.30 62.50 48.75 46.30 33.93 33.95 40.20
Research and Development Expense of Revenue
14.41% 13.92% 14.49% 14.95% 9.17% 7.58% 8.14% 10.29% 7.33% 6.59%
Selling, General and Administrative Expense of Revenue
27.39% 23.14% 22.94% 28.32% 17.13% 13.22% 20.32% 20.20% 13.79% 16.76%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
1.92% 1.47% 1.44% 1.93% 1.14% 0.54% 1.67% 2.07% 1.38% 0.93%
Graham Net Nets
0.06 0.10 (0.02) (0.28) (0.06) (0.05) (0.20) (0.49) (0.04) (0.06)
Graham Number
0.00 0.00 0.00 0.00 0.20 0.45 0.00 0.00 0.59 0.29
Earnings Yield
(5.39%) (4.73%) (8.41%) (30.39%) 2.89% 1.25% (4.69%) (13.88%) 2.67% 1.21%
Free Cash Flow Yield
(1.82%) (6.33%) (6.07%) (34.31%) (9.06%) 0.23% (8.06%) (10.28%) (1.70%) (9.52%)
Revenue per Share
0.35 0.40 0.42 0.34 0.45 0.65 0.76 0.75 0.84 0.88
Operating CF per Share
(0.01) (0.03) (0.04) (0.08) (0.05) 0.05 (0.03) (0.04) 0.03 (0.12)
Capex per Share
(0.01) 0.00 0.00 (0.02) (0.02) (0.04) (0.06) (0.02) (0.07) (0.03)
Free Cash Flow per Share
(0.01) (0.03) (0.04) (0.10) (0.08) 0.01 (0.09) (0.06) (0.04) (0.15)
Cash per Share
0.06 0.06 0.04 0.03 0.03 0.01 0.04 0.03 0.02 0.02
Shareholders Equity per Share
0.09 0.10 0.04 0.04 0.07 0.17 0.12 0.04 0.24 0.25
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.09 0.10 0.04 0.04 0.07 0.17 0.12 0.04 0.24 0.25
Free Cash Flow
(0.41) (1.03) (1.50) (3.52) (2.94) 0.45 (4.47) (3.06) (2.59) (10.71)
Working Capital
2.13 2.60 1.05 0.58 2.05 4.26 2.79 0.71 3.58 14.85
Capital Expenditures
(0.16) (0.07) (0.16) (0.74) (0.88) (1.87) (2.82) (1.05) (4.56) (2.14)
Net Current Asset Value
1.38 1.59 (0.50) (2.88) (1.97) (9.33) (11.28) (14.68) (5.71) (3.64)
EV/EBIT
0.00 0.00 0.00 0.00 22.99 77.94 0.00 0.00 31.55 80.49
Capex to Sales
0.02 0.01 0.01 0.06 0.05 0.06 0.08 0.03 0.09 0.03
Price to Operating Income
0.00 0.00 0.00 0.00 21.84 77.41 0.00 0.00 29.64 71.60
Other line items
Depreciation/Fixed assets
0.44 0.21 0.17 0.15 0.22 0.29 0.07 0.09 0.07 0.06
Cash ROIC
(8.68%) (18.42%) (40.21%) (81.33%) (46.30%) 4.90% (27.75%) (21.18%) (12.11%) (31.33%)
Accounts Receivable Turnover
22.92 16.10 14.60 13.91 8.78 8.58 8.61 9.10 12.56 10.60
Accounts Payable Turnover
12.82 10.10 8.24 5.90 5.75 7.30 5.83 4.67 4.71 6.97
Inventory Turnover
10.52 7.99 6.01 4.13 3.23 3.98 3.88 3.12 2.39 2.37
Average Days of Payables
32.37 43.95 53.83 64.49 69.70 62.62 80.21 77.53 91.79 32.52
Days of Inventory on Hand
37.36 58.64 75.06 94.23 142.29 107.03 111.41 124.23 204.58 146.88
Average Receivables
0.47 0.77 0.97 0.90 1.95 3.43 4.34 4.10 4.17 5.85
Average Payables
0.59 0.85 1.32 1.68 1.94 2.85 4.96 6.31 7.68 6.60
Average Inventory
0.72 1.08 1.81 2.40 3.45 5.22 7.47 9.44 15.15 19.39
Average Assets
4.71 5.55 6.42 7.97 11.46 20.97 30.98 33.22 41.44 50.03
Average Common Equity
2.83 3.01 2.31 1.45 2.12 5.10 6.56 3.78 8.42 16.29

Fold the line items

Columns are period end dates